Government Grants
Business Grants
Home Owner Programs
Federal Programs
About Us
Bench Testing Therapeutic/Indication Pairing Strategies (UG3/UH3)
This Funding Opportunity Announcement (FOA) invites applications for support of pre-clinical studies to repurpose existing experimental or FDA approved drugs or biologics (existing therapeutics) that have already begun or completed at least a Phase l trial.
The hypothesis for proposed studies
must be developed using innovative processes to identify the therapeutic/indication pair.
Examples include independent crowdsourcing strategies (e.g., http://www.ncats.nih.gov/ntu/assets/current, http://openinnovation.astrazeneca.com/, or any website that lists experimental therapies), or use of computational algorithms.
The initial UG3 award will support the development of milestone-driven rigorous, pre-clinical target engagement and/or efficacy studies.
Once UG3 pre-clinical milestones have been met, the UH3 award may be made to support clinical trial planning:
this includes complete planning, design, and preparation of the documentation necessary for implementation of Phase I and/or Phase II clinical trials for a new therapeutic use.
The hypothesis for proposed studies
must be developed using innovative processes to identify the therapeutic/indication pair.
Examples include independent crowdsourcing strategies (e.g., http://www.ncats.nih.gov/ntu/assets/current, http://openinnovation.astrazeneca.com/, or any website that lists experimental therapies), or use of computational algorithms.
The initial UG3 award will support the development of milestone-driven rigorous, pre-clinical target engagement and/or efficacy studies.
Once UG3 pre-clinical milestones have been met, the UH3 award may be made to support clinical trial planning:
this includes complete planning, design, and preparation of the documentation necessary for implementation of Phase I and/or Phase II clinical trials for a new therapeutic use.
Related Programs
National Center for Advancing Translational Sciences
Department of Health and Human ServicesWho's Eligible
Obtain Full Opportunity Text:
http://grants.nih.gov/grants/guide/pa-files/PAR-17-465.html
Additional Information of Eligibility:
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U. S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U. S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Full Opportunity Web Address:
Contact:
Agency Email Description:
Agency Email:
FBOWebmaster@OD.NIH.GOV
Date Posted:
2017-08-21
Application Due Date:
2020-09-07
Archive Date:
2020-10-13
Social Entrepreneurship
Spotlight
Why People Buy from Social Enterprises?
The Guardian has compiled a list of responses to its latest open thread, and has announced the winner of the social enterprise gift hamper packed with presents.
Learn How to Identify and Avoid Grant Scams
